CD8+ Cytotoxic T Cells Induce Relapsing Colitis in Normal Mice

Slides:



Advertisements
Similar presentations
Volume 141, Issue 2, Pages e2 (August 2011)
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 25, Issue 2, Pages (August 2006)
Volume 137, Issue 3, Pages (September 2009)
Volume 133, Issue 5, Pages (November 2007)
Peptide Immunization Indicates that CD8+ T Cells are the Dominant Effector Cells in Trinitrophenyl-Specific Contact Hypersensitivity  Stefan Martin, Michael.
Volume 143, Issue 5, Pages (November 2012)
Identification of CD3+CD4−CD8− T Cells as Potential Regulatory Cells in an Experimental Murine Model of Graft-Versus-Host Skin Disease (GVHD)  Fumi Miyagawa,
Volume 136, Issue 4, Pages e3 (April 2009)
Tatsukuni Ohno, Yuta Kondo, Chenyang Zhang, Siwen Kang, Miyuki Azuma 
by Norman Nausch, Ioanna E
B Cells That Produce Immunoglobulin E Mediate Colitis in BALB/c Mice
Volume 136, Issue 3, Pages (March 2009)
Volume 130, Issue 2, Pages (February 2006)
Volume 128, Issue 5, Pages (May 2005)
Hans-Peter Raué, Carol Beadling, Jennifer Haun, Mark K. Slifka 
Volume 31, Issue 5, Pages (November 2009)
Volume 143, Issue 5, Pages e4 (November 2012)
Volume 133, Issue 1, Pages (July 2007)
Therapeutic potential of follistatin for colonic inflammation in mice
Volume 141, Issue 2, Pages e4 (August 2011)
Redirection of Regulatory T Cells With Predetermined Specificity for the Treatment of Experimental Colitis in Mice  Eran Elinav, Tova Waks, Zelig Eshhar 
Volume 134, Issue 2, Pages (February 2008)
Volume 17, Issue 6, Pages (December 2002)
Effects and Regulation of Autoreactive CD8+ T Cells in a Transgenic Mouse Model of Autoimmune Hepatitis  Mario Zierden, Elisabeth Kühnen, Margarete Odenthal,
Volume 128, Issue 4, Pages (April 2005)
Galectin-1 suppresses experimental colitis in mice
Volume 141, Issue 2, Pages e2 (August 2011)
Volume 132, Issue 7, Pages (June 2007)
Volume 137, Issue 3, Pages (September 2009)
Volume 18, Issue 5, Pages (May 2003)
Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens  Hisaki Fujii,
Ananda W Goldrath, Michael J Bevan  Immunity 
Volume 140, Issue 7, Pages (June 2011)
Volume 135, Issue 3, Pages (September 2008)
Volume 130, Issue 2, Pages (February 2006)
Volume 6, Issue 4, Pages (April 1997)
Volume 141, Issue 1, Pages e1 (July 2011)
Plasmacytoid Dendritic Cells Mediate Oral Tolerance
Volume 143, Issue 1, Pages (July 2012)
Volume 31, Issue 1, Pages (July 2009)
Volume 138, Issue 2, Pages (February 2010)
Volume 132, Issue 1, Pages (January 2007)
Volume 128, Issue 3, Pages (March 2005)
Volume 29, Issue 6, Pages (December 2008)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Volume 14, Issue 1, Pages (January 2001)
Volume 135, Issue 5, Pages e5 (November 2008)
Volume 24, Issue 2, Pages (February 2006)
Volume 134, Issue 4, Pages (April 2008)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 128, Issue 4, Pages (April 2005)
Invariant NKT Cells Suppress CD8+ T-Cell–Mediated Allergic Contact Dermatitis Independently of Regulatory CD4+ T Cells  Anne Goubier, Marc Vocanson, Claire.
Afferent and Efferent Phases of Allergic Contact Dermatitis (ACD) Can Be Induced After a Single Skin Contact with Haptens: Evidence Using a Mouse Model.
Ana Belén Blázquez, Lloyd Mayer, M. Cecilia Berin  Gastroenterology 
Volume 117, Issue 3, Pages (September 1999)
Volume 18, Issue 3, Pages (March 2003)
Volume 119, Issue 1, Pages (July 2000)
Eric A Butz, Michael J Bevan  Immunity 
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 27, Issue 3, Pages (September 2007)
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Deficient Contact Hypersensitivity Reaction in CD4−/− Mice Is Because of Impaired Hapten-Specific CD8+ T Cell Functions  Pierre Saint-Mezard, Cyril Chavagnac,
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 131, Issue 2, Pages (August 2006)
Volume 28, Issue 5, Pages (May 2008)
Volume 136, Issue 7, Pages (June 2009)
Volume 131, Issue 6, Pages (December 2006)
CpG Immunostimulatory Sequences Enhance Contact Hypersensitivity Responses in Mice  Hitoshi Akiba, Masataka Satoh, Keiji Iwatsuki, Dominique Kaiserlian,
Interleukin-10-Treated Dendritic Cells Modulate Immune Responses of Naive and Sensitized T Cells In Vivo  Gabriele Müller, Anke Müller  Journal of Investigative.
Presentation transcript:

CD8+ Cytotoxic T Cells Induce Relapsing Colitis in Normal Mice Stéphane Nancey, Sébastien Holvöet, Ivan Graber, Grégoire Joubert, David Philippe, Stefan Martin, Jean–François Nicolas, Pierre Desreumaux, Bernard Flourié, Dominique Kaiserlian  Gastroenterology  Volume 131, Issue 2, Pages 485-496 (August 2006) DOI: 10.1053/j.gastro.2006.05.018 Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 1 Colitis results from a hapten-specific DTH response. (A and B) Percentage of body weight change. (A) Balb/C mice were sensitized intracolonically with DNBS in ethanol and challenged 5 days later with 1 mg of either DNBS (filled circle) or the irrelevant hapten TNBS (open square). Control (unsensitized) mice received ethanol vehicle alone on day 0 and 1 mg DNBS on day 5 (open circles). (B) DNBS-sensitized Balb/C mice challenged on day 5 with DNBS were rechallenged on day 30 with DNBS (filled circle) or ethanol alone (open circle). Results are expressed as the percentage of body weight change at various times post-challenge as compared with body weight before challenge. Data are representative of 1 of 6 experiments using 5 to 7 mice per group. (C) Histology of the colon was performed in either naive mice (panel 1) or at 72 hours post-challenge in control ethanol-injected/day 5–DNBS challenged mice (panel 2), DNBS-sensitized and day 5–DNBS-challenged mice (panel 3), DNBS-sensitized and day 5–DNBS-challenged mice injected on day 30 with ethanol alone (panel 4), or with DNBS (panel 5) (H&E staining, final magnification ×100). (D) Semiquantitative RT-PCR analysis of messenger RNA transcripts of TNF-α and IL-1β in colon samples from naive mice and day 5–DNBS-sensitized mice harvested at 24 or 48 hours after either ethanol (left) or DNBS (right) challenge. Gastroenterology 2006 131, 485-496DOI: (10.1053/j.gastro.2006.05.018) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 2 CD8+ CTL are primed by colonic DNBS sensitization. (A) T-cell proliferation assay. CD8+ and CD4+ T cells (2.105/well) purified from MLN and spleen 5 days after colonic DNBS sensitization were cultured in vitro with medium (white bar) or with mitomycin C–treated naive spleen cells (5.105/well) either unpulsed (grey bar) or pulsed with DNBS (black bar). Hapten-specific proliferation was determined on day 3 of culture by 3H-thymidine incorporation over the last 12 hours of culture. The results were expressed as mean cpm ± standard deviation of triplicate wells. (B) Frequency of hapten-specific IFN-γ–producing SFC in MLNs, CLNs, and the spleen. Total and CD8-depleted (>90% CD8 negative) cells were cultured for 24 hours at 37°C with either medium alone (white bars), TNBS (gray bars), or DNBS (black bars). Results are expressed as number of IFN-γ SFC/106 cells. (C) Hapten-specific in vivo CTL assay. Mice sensitized intracolonically on day 0 with DNBS and treated on days −1, 0, +1, and +4 with a depleting anti-CD8 mAb or control IgG mAb were injected intravenously with a 1/1 mixture of DNBS-pulsed and unpulsed spleen cells as target cells, respectively, and stained with .5 μmol/L or 5 μmol/L of CFSE. Twenty-four hours later, the percentage of stained cells in pooled MLN (black bars) and spleen (white bars) was analyzed by FACS as indicated in the materials and methods section. Results are expressed as mean ± standard deviation percentage of hapten-specific cytotoxicity. Gastroenterology 2006 131, 485-496DOI: (10.1053/j.gastro.2006.05.018) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 3 In vivo depletion of CD8+ T cells abrogates colitis. (A) Body weight change of mice was recorded at various times after colonic challenge of DNBS-sensitized mice injected with anti-CD8 mAb (open triangle), anti-CD4 mAb (open circle), or control IgG (filled circle). (B) Macroscopic (Wallace) score and (C) histologic (Ameho) score were evaluated at 72 hours after DNBS challenge in DNBS-sensitized mice treated with either control IgG (black bar) or with an anti-CD4 (white bar) or anti-CD8 mAb (shaded bar). Results are expressed as the mean score ± standard deviation in 5 mice per group and are representative of 2 experiments. (D) H&E staining of distal colon at 72 hours after DNBS challenge in DNBS-sensitized mice treated with either control IgG mAb (left panel), anti-CD4 mAb (middle panel), or anti-CD8 mAb (right panel) (final magnification ×100). Gastroenterology 2006 131, 485-496DOI: (10.1053/j.gastro.2006.05.018) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 4 Adoptive transfer of colitis by CD8+ T cells from DNBS-sensitized mice. Nude athymic mice received an enema of 1 mg of DNBS and were either untransferred (A: open triangle; B: left panel) or transferred intravenously with 10.106 CD8+ T cells from colon-draining lymph nodes harvested from Balb/C mice 5 days after ethanol injection (A: open circle; B: middle panel) or DNBS sensitization (A: filled circle; B: right panel) without challenge. (A) Body weight change is expressed as mean ± standard deviation of 1 representative experiment using 5 mice per group. (B) H&E of colon section performed at 72 hour post-challenge (final magnification ×100). Gastroenterology 2006 131, 485-496DOI: (10.1053/j.gastro.2006.05.018) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 5 CD4+ T cells from sensitized mice do not transfer colitis. Nude athymic mice received an enema of 1 mg DNBS and were either untransferred (A: filled triangle; B: panel 1) or transferred intravenously with 10.106 purified CD4+ T cells (A: open circle; B: panel 2) or CD8+ T cells (A: filled circle; B: panel 3) pooled from MLNs and the spleen from day 5 DNBS sensitized mice (no challenge). (A) Body weight change of recipient mice at various times after colonic challenge is expressed as mean of percent body weight change ± standard deviation [SD] in 5–7 mice per group. (B) H&E staining of paraffin-embedded colon sections was performed at 48 hours post-challenge (final magnification ×100). (C) Real-time RT-PCR analysis of CD4 (white) and CD8 (black) messenger RNA transcripts in distal colon of mice either untransferred or transferred with CD4+ or CD8+ T cells from DNBS-sensitized mice and harvested at 48 hours after DNBS challenge. Gastroenterology 2006 131, 485-496DOI: (10.1053/j.gastro.2006.05.018) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 6 Recruitment of IFN-γ–producing CD8+ T cells in challenged colon. Semiquantitative RT-PCR analysis of CD8 and IFN-γ transcripts (A) and immunohistochemical staining for CD8 (B) in mice DNBS-sensitized mice challenged with ethanol alone (A and B: left panels) or DNBS (A and B: right panels). Mice were sacrificed at 48 and 72 hours (A) or at 48 hours (B) after challenge (final magnification ×200). Gastroenterology 2006 131, 485-496DOI: (10.1053/j.gastro.2006.05.018) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 7 CD8+T cells recruited into the colon are specific cytotoxic effectors. Leukocytes extracted from the colon lamina propria of either ethanol- or DNBS-sensitized mice at 48 hours after DNBS challenge were cultured in vitro for 4 hours at 37°C with DNBS-pulsed syngeneic C26 colon epithelial cells. (A) FACS analysis of granzyme B–expressing CD8+ T cells on gated CD45+ cells. (B) Direct ex vivo cytotoxicity against DNBS-pulsed (black circle) or unpulsed (open circle) 51Cr-labeled C26 cells (E/T, effector to target cell ratio). Results are expressed as the percentage of specific cytotoxicity. Gastroenterology 2006 131, 485-496DOI: (10.1053/j.gastro.2006.05.018) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions